These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. IL-15 is elevated in serum and cerebrospinal fluid of patients with multiple sclerosis. Rentzos M; Cambouri C; Rombos A; Nikolaou C; Anagnostouli M; Tsoutsou A; Dimitrakopoulos A; Triantafyllou N; Vassilopoulos D J Neurol Sci; 2006 Feb; 241(1-2):25-9. PubMed ID: 16316662 [TBL] [Abstract][Full Text] [Related]
6. Serum IGF-1, IGFBP-3 and growth hormone levels in children with congenital heart disease: relationship with nutritional status, cyanosis and left ventricular functions. Dinleyici EC; Kilic Z; Buyukkaragoz B; Ucar B; Alatas O; Aydogdu SD; Dogruel N Neuro Endocrinol Lett; 2007 Jun; 28(3):279-83. PubMed ID: 17627262 [TBL] [Abstract][Full Text] [Related]
7. Changes in growth hormone and insulin-like growth factor-I levels in the acute stage after open heart surgery and at the time of discharge. Nakhjavani M; Esteghamati A; Hamidi S; Esfahanian F; Nabavi H; Abbasi M; Mirkhani SH Exp Clin Endocrinol Diabetes; 2009 Sep; 117(8):413-6. PubMed ID: 19609843 [TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid levels of iodothyronines and nerve growth factor in patients with multiple sclerosis and neuromyelitis optica. Jiang Y; Yang Y; Zhang B; Peng F; Bao J; Hu X Neuro Endocrinol Lett; 2009 Mar; 30(1):85-90. PubMed ID: 19300400 [TBL] [Abstract][Full Text] [Related]
9. Role of insulin-like growth factor-1 in colon cancerogenesis: a case-control study. Tripkovic I; Tripkovic A; Strnad M; Capkun V; Zekan L Arch Med Res; 2007 Jul; 38(5):519-25. PubMed ID: 17560457 [TBL] [Abstract][Full Text] [Related]
10. The PPAR-gamma activator rosiglitazone fails to lower plasma growth hormone and insulin-like growth factor-1 levels in patients with acromegaly. Bastemir M; Akin F; Yaylali GF Neuroendocrinology; 2007; 86(2):119-23. PubMed ID: 17671378 [TBL] [Abstract][Full Text] [Related]
11. Pregnancy-induced changes in insulin-like growth factor I (IGF-I), insulin-like growth factor binding protein 3 (IGFBP-3), and acid-labile subunit (ALS) in patients with growth hormone (GH) deficiency and excess. Wiesli P; Zwimpfer C; Zapf J; Schmid C Acta Obstet Gynecol Scand; 2006; 85(8):900-5. PubMed ID: 16862465 [TBL] [Abstract][Full Text] [Related]
12. The insulin-like growth factor system in multiple sclerosis. Chesik D; Wilczak N; De Keyser J Int Rev Neurobiol; 2007; 79():203-26. PubMed ID: 17531843 [TBL] [Abstract][Full Text] [Related]
13. Fibroblast growth factor-2 levels are elevated in the cerebrospinal fluid of multiple sclerosis patients. Sarchielli P; Di Filippo M; Ercolani MV; Chiasserini D; Mattioni A; Bonucci M; Tenaglia S; Eusebi P; Calabresi P Neurosci Lett; 2008 Apr; 435(3):223-8. PubMed ID: 18353554 [TBL] [Abstract][Full Text] [Related]
14. Is further evaluation for growth hormone (GH) deficiency necessary in fibromyalgia patients with low serum insulin-like growth factor (IGF)-I levels? Yuen KC; Bennett RM; Hryciw CA; Cook MB; Rhoads SA; Cook DM Growth Horm IGF Res; 2007 Feb; 17(1):82-8. PubMed ID: 17289417 [TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age. Cutfield WS; Lundgren F Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504 [TBL] [Abstract][Full Text] [Related]
16. Comparison between weight-based and IGF-I-based growth hormone (GH) dosing in the treatment of children with GH deficiency and influence of exon 3 deleted GH receptor variant. Marchisotti FG; Jorge AA; Montenegro LR; Berger K; de Carvalho LR; Mendonca BB; Arnhold IJ Growth Horm IGF Res; 2009 Apr; 19(2):179-86. PubMed ID: 19036620 [TBL] [Abstract][Full Text] [Related]
17. Short stature and decreased insulin-like growth factor I (IGF-I)/growth hormone (GH)-ratio in an adult GH-deficient patient pointing to additional partial GH insensitivity due to a R179C mutation of the growth hormone receptor. Meyer S; Ipek M; Keth A; Minnemann T; von Mach MA; Weise A; Ittner JR; Nawroth PP; Plöckinger U; Stalla GK; Tuschy U; Weber MM; Kann PH; ; Growth Horm IGF Res; 2007 Aug; 17(4):307-14. PubMed ID: 17462934 [TBL] [Abstract][Full Text] [Related]
18. Amino acid profiles in adults with growth hormone (GH) deficiency before and during GH replacement therapy. Fernholm R; Thoren M; Hoybye C; Anderstam B; Pernow Y; Saaf M; Hall K Growth Horm IGF Res; 2009 Jun; 19(3):206-11. PubMed ID: 18990596 [TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid and serum levels of insulin-like growth factor-1 and insulin-like growth factor binding protein-3 in patients with severe head injury. Sanus GZ; Tanriverdi T; Coşkun A; Hanimoğlu H; Is M; Uzan M Ulus Travma Acil Cerrahi Derg; 2007 Oct; 13(4):281-7. PubMed ID: 17978909 [TBL] [Abstract][Full Text] [Related]
20. Specificity and correlation with disease activity of cerebrospinal fluid osteopontin levels in patients with multiple sclerosis. Chowdhury SA; Lin J; Sadiq SA Arch Neurol; 2008 Feb; 65(2):232-5. PubMed ID: 18268193 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]